New York, November 4, 2004 – Combination therapy with Pfizer Inc's DETROL® LA (tolterodine tartrate extended ... were treated with alpha blocker doxazosin for three months.

[24] Despite such a pronounced placebo effect in the present study, patients on tolterodine demonstrated consistently greater improvements in micturition diary variables compared with placebo.

Serlopitant, a neurokinin-1 receptor antagonist, offers no advantage over tolterodine for the treatment of adult overactive bladder (OAB), according to the results of a multicenter randomized ...

The symptoms began several weeks after she began to take tolterodine (2 mg twice daily) for urinary incontinence. These hallucinations did not distress the patient and resolved after three months ...

In conclusion, tolterodine 2mg twice daily is well tolerated and provides clinically meaningful improvements in the chronic and debilitating symptoms that characterise the overactive bladder ...